Manuel C. Alves Aivado's most recent trade in Rein Therapeutics Inc. was a trade of 17,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rein Therapeutics Inc. | Manuel C. Alves-Aivado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2025 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | Manuel C. Alves-Aivado | Director | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | ||
| Rein Therapeutics Inc. | Manuel C. Alves-Aivado | Director | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | ||
| Rein Therapeutics Inc. | Manuel C. Alves Aivado | Director, See Remarks | 30 Mar 2022 | 1,133,000 | 1,133,000 | - | - | Stock Option (right to buy) | ||
| Rein Therapeutics Inc. | Manuel C. Alves Aivado | Director, See Remarks | 15 Jun 2021 | 2,440,000 | 2,440,000 | - | - | Stock Option (right to buy) |